Report #2824528

Received Feb 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Rash

Symptom narrative

patients that have developed a skin rash; This non-serious case was reported by a physician via sales rep and described the occurrence of skin rash in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the unspecified number of patients patient received Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced skin rash (Verbatim: patients that have developed a skin rash). The outcome of the skin rash was unknown. The reporter considered the skin rash to be related to Shingrix. The company considered the skin rash to be related to Shingrix. Additional Information: GSK Receipt Date:06-JAN-2025 Physician mentioned that he had patients that have developed a skin rash following a dose of Shingrix.